BackNatural Alternatives International Overview

Natural Alternatives International Accounts Payable

Latest accounts payable for NAII: $18M.

Get informed when a big investor buys or sells

+ Follow
Accounts Payable
$18.16M
↑ 41.61% YoYΔ $5.33M vs prior year quarter

Peer trimmed avg / median

Loading

Natural Alternatives International Accounts Payable History

Loading

Natural Alternatives International vs. peers: Accounts Payable Comparison

Loading

Natural Alternatives International Accounts Payable Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Natural Alternatives International (NAII) FAQ

Natural Alternatives International posts a accounts payable of $18M as of March 2026. That compares with $13M in the prior-year period — up 41.6% year over year. Comparing that reading with peers and prior periods is usually more useful than looking at the number in isolation.

In the prior comparable period, Natural Alternatives International's accounts payable was $13M. The latest reading is $18M — a 41.6% year-over-year increase (period ending March 2026). Use the history and growth charts on this page for a longer lookback.

Accounts Payable is one piece of Natural Alternatives International's financial statement story. At $18M, it should be interpreted next to related metrics — for example revenue with costs, assets with liabilities, or income with margins. Stockcircle links those related pages so you can move from this number to the surrounding context quickly.

Context for NAII's accounts payable usually means three checks: (1) trend versus prior periods, (2) level versus peers, and (3) consistency with growth and profitability. This page covers the first two; Natural Alternatives International's other metric pages and overview cover the third.

Judging Natural Alternatives International against Healthcare peers is usually better than using a market-wide rule of thumb. Business models inside Healthcare are more comparable, which makes gaps in accounts payable easier to interpret. Start with $18M here, then scan peer and history charts to see if the gap is persistent.